NeoChord, a specialist in minimally-invasive repair of mitral valve prolapse, has appointed former Edwards Lifesciences senior executive David Chung president and CEO. Mr Chung replaces John Seaberg, who has resigned after seven years at the helm of the Eden Prarie, Minnesota firm.
The company declined to comment on where Mr Seaberg has gone on to.